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Seroepidemiology and risk factors of hepatitis C virus infection 
in East Azerbaijan, Iran: a population-based Azar Cohort 
study 
Abstract 
Background: Hepatitis C virus (HCV) is a blood-borne virus. It is a major global public 
health problem and can cause both acute and chronic hepatitis. The aim of this study was 
to report the epidemiological features of HCV infection and risk factors based on the data 
from Azar Cohort, East Azerbaijan province, Iran. 
Methods: The population of this study comprised the people in the age range of 35-70 
years from Azar Cohort, East Azerbaijan province, Iran. The study was conducted between 
2015 and 2016. Based on cluster sampling, 4, 949 people were selected and invited to 
complete the questionnaire and perform the tests. Blood samples collected in this study 
were analyzed to detect the presence of antibodies against HCV using enzyme 
immunoassay (ELISA) Kit. The positive samples were re-tested by qualitative HCV-RNA 
polymerase chain reaction. All data were analyzed using SPSS version 19.0 software. 
Results: The mean age of the participants was 49.15±9.02 years. Of these participants, 
54.3% (n=2686) were females. Seven people (0.14%) were detected as HCV positive and 
the highest frequency was seen in the age range of 40-50 (0.16%). There was a statistical 
significant relationship between history of hospitalization (P=0.02) and history of 
abnormal urine (P=0.01) with the frequency of HCV infection. 
Conclusion: The findings of this study indicated that the frequency of hepatitis C virus 
infection is 0.14% in the general population of Azar Cohort. 
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Hepatitis C is a liver disease caused by hepatitis C virus (HCV). Acute HCV 
infection is usually asymptomatic and about 35% of the infected people spontaneously 
clear the virus infection within 6 months without any treatment (1). Meanwhile, 60-80% of 
HCV patients develop chronic hepatitis infection and 20% are at risk for cirrhosis and liver 
cancer, and approximately 350,000 people die every year from the complications of 
hepatitis C disease (2).
 
The prevalence of hepatitis C in the world is an average of 3%, and 
about 185 million people are infected with hepatitis C virus (3). Hepatitis C virus is the 
second leading cause of chronic liver disease and the most important cause of liver cancer 
and liver transplantation (4). In terms of geographical dispersion among Middle Eastern 
countries, the prevalence of hepatitis C virus is often high in Egypt (14.5%), Pakistan 
(4%), Saudi Arabia (1.8%) and Yemen (1.1%) (5). Iran has a low hepatitis C prevalence in 
the region. According to a survey conducted in Iran, the seroprevalence of hepatitis C 
infection was 0.6% and the prevalence of viremia was 0.4% (6);
 
186,500 people were infected 
with HCV (7) and almost 80% of the infected people were unaware of their disease (8).  
Unfortunately, the prevalence of this virus is increasing in the country, which necessitates 
careful analysis of this disease with the aim of taking the related health decisions (9). 
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The groups that are at high risk of HCV infection include 
hemophilias, thalassemic and hemodialysis patients and 
intravenous drugs addicts. These people can cause the 
infection to be transmitted to healthy people (6). According 
to the previous reports, the prevalence of hepatitis C virus in 
hemophiliacs, thalassemic patients, hemodialysis patients 
and intravenous drugs addicts is more than 40%, more than 
20%, 13 to 18% and 11 to 52%, respectively (10, 11). The 
routes of transmission of hepatitis C infection are 
intravenous drug use, infected medical equipment, tattooing, 
needle stick, hemodialysis, infected blood and blood product, 
unsafe sexual activity and organ transplantation (9). 
In the past, the most common way of hepatitis C 
transmission was blood transfusion, but after screening the 
blood donors since 1996, the predominant pathway of 
dissemination has been reported nosocomially (12). HCV 
infection is the main cause of mortality and disability and 
imposes financial costs on the communities and it is one of 
the major health issues in the world (13). There is no vaccine 
for hepatitis C, so early diagnosis can prevent the health 
problems caused by the hepatitis C virus infection. The risk 
of transmission of infectious diseases through blood 
transfusions is measurable by checking and analyzing the 
donors' information, screening methods and the incidence of 
serological markers of infectious diseases. Since the number 
of demographic studies carried out in East Azerbaijan 
province is limited and previous studies have merely 
investigated some certain groups of the community, and 
considering the impact of these infections on mortality rate, 
the cost of treatment and other socially harmful effects, this 
study was designed to determine the frequency and risk 
factors of hepatitis C virus transmission in this area. 
 
 
Methods 
This project was part of Azar Cohort study in Shabestar, 
East Azerbaijan province (North West of Iran) and is part of 
large Persian cohort study (Prospective Epidemiological 
Research Studies of Iranian Adults) (14, 15). This cross-
sectional study consisted of 5,000 males and females ranging 
from 35 to 70 were included between 2015 and 2016. The 
method of sampling was cluster sampling, including 50 
clusters (100 subjects in each) from the mentioned county. In 
this cohort study, the first house on the right of the nearest 
street to the center of Azar Cohort was selected as the first 
household for each cluster randomly. After explaining the 
stages of the research for the included individuals, they were 
invited to the head office of the study for evaluation. Out of 
the 5,000 subjects, 51 people refused to get involved or were 
unable to participate and were excluded from the study, 
leaving a total of 4,949 individuals as the final sample. 
The inclusion criteria were: residence in that area for 
more than a year, Iranian nationality, ability to answer to the 
questions and willingness to participate in the study. After 
starting the conduct of the research project, three separate 
groups were formed for interview, taking blood sample and 
laboratory analysis. A written and informed consent was 
obtained from the subjects prior to data collection. Then, a 
questionnaire containing demographic characteristics and 
risk factors for hepatitis such as age, sex, residence, level of 
education, marital status, history of blood transfusion, 
surgery, hospitalization, dental procedures, fatty liver, family 
history of hepatitis, traveling abroad, drug abuse, smoking 
and alcohol use was completed for all the eligible 
participants through face-to-face interviews. From each 
person, 10 
cc
 of blood sample was taken. The blood samples 
were centrifuged, and the serums were separated and stored 
in micro tubes at -80 °C. The samples collected in this study 
were used for the detection of the presence of antibodies 
against HCV using enzyme immunoassay (ELISA) Kit, Anti 
HCV Ab (PISHTAZTEB, Tehran, Iran). Positive samples 
were re-tested by qualitative HCV-RNA polymerase chain 
reaction using HCV RQ Kit, produced by Novin Gene, Iran.  
The data were entered into SPSS.19 software. The 
qualitative data were analyzed using Chi-Square or Fisher's 
exact test with crude odds ratio (95%CI). The P-value less 
than 0.05 was considered as statistically significant. 
 
 
Results 
Out of the total of 4,949 subjects, 2,686 individuals were 
females (54.3%) with an average age of 49.15±9.02 years 
(age range 35-70 years). Most participants were between 40-
50 years of age (36.9%), married (93.4%) and non-employed 
(50.6%). Table 1 shows the demographic data of the 
participants in this HCV study. From among all the 
participants, 7 cases were identified as HCV Ab-positive by 
ELISA. Out of these people, 4 (out of 2,686 i.e., 0.14%) 
were females and 3 (2,263 i.e., 0.13%) were males, which 
indicates 57.1% and 42.8% among all the infected cases, 
respectively. The mean age for HCV Ab positive subjects 
was 50.29±10.35 years. Thus, the frequency of HCV Ab 
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positive cases by ELISA was 0.14%, [95%CI (0.25-5.02)]. 
All HCV Ab-positive cases were tested by HCV RNA. The 
results showed that no patient was positive for HCV RNA. 
Table 1. Some Demographic data of the study 
participants (N=4949). 
Variables No. (%) 
Female 2686 (54.3) 
Married groups 4621 (93.4) 
History of surgery 2931 (59.2) 
History of hospitalization 3842 (77.6) 
History of blood transfusion 318 (6.4) 
Drug addiction 123 (2.5) 
Dental procedures 2560 (51.7) 
Traveling abroad 2103 (42.5) 
Abnormal urine test 1485 (30) 
The highest frequency of HCV Ab was observed in the 
age group of 40-50 years (0.16%), followed by 50-60 and 
60-70 age groups. In males, the highest frequency of anti 
HCV was seen in the age group less than 40 years (0.23%), 
and in females the age group of 60-70 years (0.3%). The 
frequency in the males of 60-70 age group and females less 
than 40 years was zero. The rate of HCV Ab in the married 
group was 0.15%. Regarding the level of education, the 
highest frequency of HCV infection in those with university 
degree was 0.62% and in the group with primary education 
was zero. In this study, the risk factors for hepatitis C 
infection were evaluated in all participants. The major risk 
factor was hospitalization (77.6%) followed by the history of 
surgery, dental procedures, occupation and history of blood 
transfusion.  
Table 2.Comparsion of the effects of different variables and main risk factors in anti HCV positive patients (N=4949). 
Variable 
Anti-HCV Ab£ ELISA¥, No. (%) P value* 
(Chi-Square) 
Crude OR  
(95% CI) Positive Negative 
Gender 
Male 3(0.13) 2260 (99.87) 
0.87 1.22 (0.27-5.48) 
Female 4(0.14) 2682 (99.86) 
Marital Status 
Single 0(0) 76 (100) 
0.91 0.54(0.03-11.00) 
Married 7(0.15) 4614 (99.85) 
Age (Year) 
<40 1(0.09) 1039 (99.91) 
0.9 
Ref 
40-50 3(0.16) 1823 (99.84) 1.71(0.17-16.45) 
50-60 2(0.14) 1406 (99.86) 1.47(0.13-16.32) 
> 60 1(0.14) 674 (99.86) 1.54(0.09-24.68) 
Educational level 
Illiterate 2(0.18) 1094 (99.82) 
0.74 
Ref 
Elementary 0(0) 1349 (100) - 
Mid school 2(0.24) 813 (99.76) 1.34(0.18-9.57) 
High school  1(0.11) 842 (99.89) 0.65(0.06-7.17) 
University 2(0.62) 844 (99.38) 1.29(0.18-9.22) 
Occupation 
Employed 4(0.20) 2439 (99.80)  
0.68 1.36 (0.30-6.12) 
None 3(0.11) 2503 (99.89) 
History of surgery 
 Yes 2(0.06) 2929 (99.94) 
0.09 0.27 (0.05-1.41) 
 No 5(0.25) 2013(99.75) 
History of hospitalization 
 Yes 3(0.07) 3839 (99.93) 
0.02 0.21 (0.48-0.96) 
 No 4(0.36) 1103(99.64) 
History of blood transfusion 
 Yes 0(0) 318 (100) 
0.48 - 
 No 7(0.15) 4624(99.85) 
Drug addiction 
 Yes 1(0.80) 122 (99.20) 
0.16 6.58 (0.78-55.11) 
 No 6(0.12) 4820(99.88) 
Dental procedures 
 Yes 2(0.10) 2558 (99.90) 
0.22 0.37 (0.07-1.92) 
 No 5(0.20) 2384(99.80) 
Traveling abroad 
Yes 4(0.19) 2099 (99.81) 
0.43 1.80 (0.40-8.07) 
No 3(0.10) 2843(99.90) 
Abnormal urine test 
 Yes 5(0.33) 1480 (99.67) 
0.01 5.84 (1.13-30.17) 
 No 2(0.05) 3462(99.95) 
                         £Anti hepatitis C virus antibody.              ¥ Enzyme-linked immunosorbent assay.          *P-value <0.05 was statistically significant. 
 
Table 2 shows comparison of the effects of different 
variables and main risk factors in anti-HCV-positive  
 
patients. The history of hospitalization (P=0.02) and 
abnormal urine (P=0.01) was associated with the frequency 
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of HCV infection. The history of hospitalization [Crude OR= 
0.21, 95%CI (0.48 - 0.96)] and history of abnormal urine 
[Crude OR=5.84, 95% CI (1.13-30.17)] had a statistical 
significant relationship with the frequency of HCV infection. 
There was no association between HCV Ab and family 
history of hepatitis, history of surgery, blood transfusion, 
dental procedures and occupation. 
 
 
Discussion 
This research project is the first epidemiological study in 
which the seroprevalence of HCV infection and its related 
risk factors has been investigated among the general 
population in the age group of 35-70 years. The study was 
performed as part of the Azar Cohort project between 2015 
and 2016. Hepatitis C virus is a major factor for chronic liver 
disease and increases the progress of hepatic-cirrhosis and 
hepatocellular carcinoma. The incidence of HCV infection 
has been investigated among high risk groups in the previous 
studies and few population-based studies have been designed 
in this regard. The frequency of hepatitis C infection in 
different regions of Iran varies from 0.08% to 1.6% (6). The 
reasons for this heterogeneity might be related to such items 
as lifestyles, high-risk behaviors, overall quality of health 
services, cultural conditions, geographic dispersion of Iran 
and the impact of neighboring countries. 
In this study, the frequency of anti-HCV was 0.14% by 
ELISA, which was lower than similar studies in provinces of 
Chahar Mahal and Bakhtiari (16),
 
Fars (18) and cities of 
Amol (17),
 
and Mashhad (19). Since this project was 
conducted in an area with religious background where family 
ties are strongly kept and there is a low level of social 
deprivation, the results can be considered as effective. 
The frequency of HCV infection in females was higher 
than that of males, which is not in line with the results of the 
studies conducted by Moezzi et al. (16) and Zamani et al. 
(17)
 
Meanwhile the results are consistent with the study of 
Akkaya et al. (20). This might be justified by the fact that the 
number of females included in this study was higher than 
that of males (54.3% females and 45.7% males). Also, there 
was no significant relationship between HCV infection and 
age, which is similar to the findings of the studies by 
Alizadeh et al. (21) and Teutsch et al. (22), but different 
from the results of the study by Miller et al. (23).
 
This 
difference may be justified by the fact that HCV infection 
can be seen at any age. The highest frequency of HCV 
infection was found in the 40-50 year age group which is in 
line with the results of the studies by Moezzi et al. (16) and 
Shakeri et al. (19),
 
though it differs from the findings of 
Fattahi et al. (18). The probable differences in lifestyles,  
ethnic groups, population density and community education 
about hepatitis C virus might justify the source of such 
contradictions. 
The frequency of anti-HCV in the married group was 
0.15%, which is higher than single individuals. This is also 
consistent with the study by Qureshi et al. (24). Regarding 
the level of education, in the present study, there was no 
significant relationship between education level and HCV 
infection. This finding was also found in the study of 
Alizade et al. (21). But there was a significant correlation 
between education level and HCV in the study of Todd et al 
(25), which indicates that the prevalence of anti HCV has 
been higher among  those with lower education levels, which 
contradicts with our study. Assessing the risk factors for 
HCV infection in participants was another objective of this 
study. There was a significant relationship between the risk 
factors and factors influencing the transmission of the 
disease including hospitalization history and urine color 
changes. This is also consistent with the results of other 
studies (26, 27, 28). According to the study by Merat et al., 
the two factors of imprisonment and drug abuse were 
associated with HCV infection (10). 
In a study performed by Zamani et al. non-sterile 
piercing and a history of first-degree affected relatives were 
identified as the major risk factors (17). Therefore, designing 
appropriate plans, screening for the acute disease, finding the 
affected people along with treating and controlling them 
should be seriously considered in the national plan in an 
attempt to eradicate the hepatitis C. 
Certain patients, such as those with thalassemia, 
hemophilia and those who undergo dialysis, are also the 
major groups of known patients due to their frequent needs 
for blood transfusions and blood products. Due to the careful 
control of blood donations, the chance of getting infected 
with hepatitis C has decreased significantly in the recent 
years. One of the reasons for the low spread of hepatitis C in 
Iran is the implementation of social programs to reduce the 
harm caused by addiction in the country. The limitations of 
this study included the absence of some high-risk behaviors 
and risk factors for hepatitis C, along with the recall bias of 
being exposed to some of the possible risk factors. The 
participants of this study were enrolled from Azar Cohort 
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project with the age range of 35-70. We should mention that 
considering the age groups less than 35 years could have 
altered the results of this study. 
In conclusion, the following measurements should be 
fulfilled to reduce the incidence of hepatitis C: a 
comprehensive analysis of all the risk factors for hepatitis C 
along with a comprehensive definition of all the risk factors, 
increasing public awareness on the transmission routes, risk 
reduction strategies in high risk groups, providing free 
laboratory services for the community, modifying the 
information gathering system. 
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